SHORT COMMUNICATION
Dengue virus and Japanese encephalitis virus infection of the central nervous system share similar profiles of cytokine accumulation in cerebrospinal fluid
 
More details
Hide details
 
Submission date: 2016-05-07
 
 
Final revision date: 2016-08-29
 
 
Acceptance date: 2016-09-06
 
 
Publication date: 2017-08-08
 
 
Cent Eur J Immunol 2017;42(2):218-222
 
KEYWORDS
ABSTRACT
Dengue virus (DENV) and Japanese encephalitis virus (JEV) are two important pathogenic viruses that can cause severe encephalitis, which is accompanied by inflammatory cytokines. However, the inflammatory cytokine content of cerebrospinal fluid (CSF) in DENV and JEV infection of central nervous system are not sufficiently studied. To investigate cytokine levels in serum and CSF of hospitalised children with DENV and JEV infection of the central nervous system, a total of 183 hospitalised children with viral encephalitis-like syndrome were enrolled between May 2014 and April 2015 at the Children’s Hospital of Chenzhou, Hunan, China. DENV and JEV infection was diagnosed by ELISA. Cytokine levels in the serum and CSF were measured by commercial ELISA kits. Twenty-nine (15.85%) and 26 (14.21%) DENV and JEV infections were detected in 183 patients with viral encephalitis-like syndrome, respectively. Higher granulocyte-macrophage colony-stimulating factor (GM-CSF) levels were detected in the serum of JEV infected patients than in DNEV patients (p < 0.05) or in healthy controls (p < 0.001), and levels of GM-CSF, interleukin 6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) were higher in the CSF than serum in both DENV and JEV infection. Both DENV and JEV infection induced similar cytokine accumulation profiles in the CSF, which probably contributed to DENV- and JEV-induced immunopathogenesis.
REFERENCES (23)
1.
Diaz-Quijano FA (2012): Dengue. N Engl J Med 367: 180; author reply 181.
 
2.
Pok KY, Squires, RC, Tan LK, et al. (2015): First round of external quality assessment of dengue diagnostics in the WHO Western Pacific Region, 2013. Western Pac Surveill Response J 6: 73-81.
 
3.
Kumar A, Gittens-St Hilair M, Jason V, et al. (2015): The clinical characteristics and outcome of children hospitalized with dengue in Barbados, an English Caribbean country. J Infect Dev Ctries 9: 394-401.
 
4.
Matlani M, Chakravarti A, Rawal A, et al. (2009): Dengue encephalitis: an entity now common in dengue-prone regions. Trop Doct 39: 115-116.
 
5.
Shen JC, Luo L, Li L, et al. (2015): The Impacts of Mosquito Density and Meteorological Factors on Dengue Fever Epidemics in Guangzhou, China, 2006-2014: a Time-series Analysis. Biomed Environ Sci 28: 321-329.
 
6.
Tsai TT, Chuang YJ, Lin YS, et al. (2013): An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci 20: 40.
 
7.
Raghupathy R, Chaturvedi UC, Al-Sayer H, et al. (1998): Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56: 280-285.
 
8.
Priyadarshini D, Gadia RR, Tripathy A, et al. (2010): Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5: e8709.
 
9.
Chen LC, Lei HY, Liu CC, et al. (2006): Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg 74: 142-147.
 
10.
Bozza FA, Cruz OG, Zagne SM, et al. (2008): Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8: 86.
 
11.
de-Oliveira-Pinto LM, Gandini M, Freitas LP, et al. (2012): Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1beta and CCL2/MCP-1 in dengue fever and parvovirosis. Mem Inst Oswaldo Cruz 107: 48-56.
 
12.
Amaral DC, Rachid MA, Vilela MC, et al. (2011): Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice. J Neuroinflammation 8: 23.
 
13.
Kalita J, Srivastava R, Mishra MK, et al. (2010): Cytokines and chemokines in viral encephalitis: a clinicoradiological correlation. Neurosci Lett 473: 48-51.
 
14.
Burke DS, Morill JC (1987): Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis. J Infect Dis 155: 797-799.
 
15.
Ravi V, Parida S, Desai A, et al. (1997): Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J Med Virol 51: 132-136.
 
16.
Singh A, Kulshreshtha R, Mathur A (2000): Secretion of the chemokine interleukin-8 during Japanese encephalitis virus infection. J Med Microbiol 49: 607-612.
 
17.
Winter PM, Dung NM, Loan HT, et al. (2004): Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J Infect Dis 190: 1618-1626.
 
18.
Ghoshal A, Das S, Ghosh S, et al. (2007): Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55: 483-496.
 
19.
Giri A, Arjyal A, Koirala S, et al. (2013): Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study. Sci Rep 3: 2382.
 
20.
Yavarian J, Gavvami N, Mamishi S (2014): Detection of human herpesvirus 6 in cerebrospinal fluid of children with possible encephalitis. Jundishapur J Microbiol 7: e11821.
 
21.
Lanciotti RS, Calisher CH, Gubler DJ, et al. (1992): Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545-551.
 
22.
Zhai Y, Zhou Y, Li X, et al. (2015): Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Mol Med Rep 12: 199-209.
 
23.
Zhang JS, Zhao QM, Zuo SQ, et al. (2012): Cytokine and chemokine responses to Japanese encephalitis live attenuated vaccine in a human population. Int J Infect Dis 16: e285-288.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top